Armata Pharmaceuticals (ARMP) Net Cash Flow Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 453.08% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -125.22% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 53.46% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -325.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -325.57% |
| Dec 31, 2025 | 22.70% |
| Sep 30, 2025 | 212.56% |
| Jun 30, 2025 | 35.75% |
| Mar 31, 2025 | -90.43% |
| Dec 31, 2024 | 25.51% |
| Sep 30, 2024 | -179.82% |
| Jun 30, 2024 | 9.45% |
| Mar 31, 2024 | 140.63% |
| Dec 31, 2023 | -0.09% |
| Sep 30, 2023 | 200.09% |
| Jun 30, 2023 | -34.15% |
| Mar 31, 2023 | -75.50% |
| Dec 31, 2022 | -488.93% |
| Sep 30, 2022 | -112.38% |
| Jun 30, 2022 | -91.71% |
| Mar 31, 2022 | 219.23% |
| Dec 31, 2021 | 71.33% |
| Sep 30, 2021 | -39.96% |
| Jun 30, 2021 | -28.67% |
| Mar 31, 2021 | -29.15% |
| Dec 31, 2020 | -134.70% |
| Sep 30, 2020 | 13.35% |
| Jun 30, 2020 | -154.38% |
| Mar 31, 2020 | 601.97% |
| Dec 31, 2019 | -212.63% |
| Sep 30, 2019 | -116.96% |
| Jun 30, 2019 | 437.98% |
| Mar 31, 2019 | -217.14% |
| Dec 31, 2018 | 190.98% |
| Sep 30, 2018 | -67.74% |
| Jun 30, 2018 | -130.77% |
| Mar 31, 2018 | 187.60% |
| Dec 31, 2017 | -248.68% |
| Sep 30, 2017 | 61.06% |
| Jun 30, 2017 | 324.06% |
| Mar 31, 2017 | -9.76% |
| Dec 31, 2016 | 173.68% |
| Sep 30, 2016 | -21.54% |
| Jun 30, 2016 | -32.67% |